Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 8/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | HTR3A | P46098 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.34 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL936662 | 0.85 | NOTUM (0.43) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL1041749 | 0.85 | NOTUM (0.43) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL22969778 | 0.85 | NOTUM (0.43) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL29449840 | 0.85 | NOTUM (0.43) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL4730343 | 0.83 | NOTUM (0.57) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL3278921 | 0.83 | NOTUM (0.42) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL5995973 | 0.83 | NOTUM (0.42) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL3786889 | 0.83 | TSHR (0.48) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL11609195 | 0.83 | NOTUM (0.42) | NOTUMCYP1A2CYP2A6TSHRLMNA | |
| SCHEMBL9259048 | 0.83 | TSHR (0.50) | NOTUMCYP1A2CYP2A6TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683484-A1 | BINUCLEAR METAL COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | CREDOXYS GmbH (DE) | 2026-01-21 | — | — | EP | disclosed |
| US-12486343-B2 | Method for producing iodine-containing compound, and iodine-containing compound | AGC Inc. (JP) | 2025-12-02 | — | — | US | disclosed |
| CN-118119583-A | Method for producing fluorine-containing aromatic compound | 大金工业株式会社 | 2024-05-31 | — | — | CN | disclosed |
| EP-4212553-A1 | METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND | AGC INC. (JP) | 2023-07-19 | — | — | EP | disclosed |
| US-20230203215-A1 | METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND | AGC Inc. (JP) | 2023-06-29 | — | — | US | disclosed |
| WO-2023063301-A1 | METHOD FOR PRODUCING FLUORINATED AROMATIC COMPOUND | ダイキン工業株式会社 | 2023-04-20 | — | — | WO | disclosed |
| WO-2022053010-A1 | FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES | Janssen Sciences Ireland Unlimited Company (IE) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022053010-A1 | FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES | Janssen Sciences Ireland Unlimited Company (IE) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022054547-A1 | METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND | ＡＧＣ株式会社 | 2022-03-17 | — | — | WO | disclosed |
| WO-2020189540-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | 中外製薬株式会社 | 2020-09-24 | — | — | WO | disclosed |
| CN-102320919-B | Preparation method for 2,6-dichloro-trifluorotoluene | JIANGSU WEIER CHEMICAL CO LTD | 2014-07-23 | — | — | CN | disclosed |
| US-20140193742-A1 | BLOCK COPOLYMER, MANUFACTURING METHOD THEREFOR, AND POLYMER ELECTROLYTE MATERIAL, MOLDED POLYMER ELECTROLYTE, AND SOLID-POLYMER FUEL CELL USING SAID BLOCK COPOLYMER | TORAY INDUSTRIES, INC. (JP) | 2014-07-10 | — | — | US | disclosed |
| US-20140193742-A1 | BLOCK COPOLYMER, MANUFACTURING METHOD THEREFOR, AND POLYMER ELECTROLYTE MATERIAL, MOLDED POLYMER ELECTROLYTE, AND SOLID-POLYMER FUEL CELL USING SAID BLOCK COPOLYMER | TORAY INDUSTRIES, INC. (JP) | 2014-07-10 | — | — | US | disclosed |
| EP-2749585-A1 | BLOCK COPOLYMER, MANUFACTURING METHOD THEREFOR, AND POLYMER ELECTROLYTE MATERIAL, MOLDED POLYMER ELECTROLYTE, AND SOLID-POLYMER FUEL CELL USING SAID BLOCK COPOLYMER | Toray Industries, Inc. (JP) | 2014-07-02 | — | — | EP | disclosed |
| WO-2013078070-A1 | BORON-CONTAINING SMALL MOLECULES | ELI LILLY AND COMPANY (US) | 2013-05-30 | — | — | WO | disclosed |
| US-20130131016-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| CN-102320919-A | Preparation method for 2,6-dichloro-trifluorotoluene | JIANGSU WEIER CHEMICAL CO LTD | 2012-01-18 | — | — | CN | disclosed |
| CN-102320919-A | Preparation method for 2,6-dichloro-trifluorotoluene | JIANGSU WEIER CHEMICAL CO LTD | 2012-01-18 | — | — | CN | disclosed |
| US-5744437-A | BENZOTRIFLUORIDE SOLVENT, GLYCOL ETHER COSOLVENT, ALKANOL, SURFACTANT, WATER | OCCIDENTAL CHEMICAL CORPORATION (US) | 1998-04-28 | — | — | US | disclosed |
| WO-1996015200-A1 | SINGLE PHASE LIQUID COMPOSITION FOR CLEANING AND PAINT STRIPPING | OCCIDENTAL CHEMICAL CORPORATION (US) | 1996-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131016-A1 | BORON-CONTAINING SMALL MOLECULES | BCL6B, SLC7A5, BCL6 | NOTUM 4664/4885CYP1A2 2434/4885CYP2A6 1150/4885 |
| US-20230203215-A1 | METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND | SSTR2, TPO, BRI3BP | NOTUM 2842/4885CYP1A2 142/4885CYP2A6 641/4885 |
| US-12486343-B2 | Method for producing iodine-containing compound, and iodine-containing compound | SSTR2, TPO, BRI3BP | NOTUM 2842/4885CYP1A2 142/4885CYP2A6 641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.